UNCOUPLING THE OXIDATIVE PHOSPHORYLATION IN THE COMBINED CHEMOTHERAPY OF CANCER.
D000255:Adenosine Triphosphate; D000963:Antimetabolites; D000970:Antineoplastic Agents; D002279:Carcinoma 256, Walker; D002746:Chlorpromazine; D003520:Cyclophosphamide; D004359:Drug Therapy, Combination; D008660:Metabolism; D008928:Mitochondria; D009369:Neoplasms; D009374:Neoplasms, Experimental; D010085:Oxidative Phosphorylation; D010600:Pharmacology; D051381:Rats; D012106:Research; D012509:Sarcoma; D012513:Sarcoma, Experimental; D014284:Triiodothyronine
D000963:Antimetabolites; D000970:Antineoplastic Agents; D014284:Triiodothyronine; D000255:Adenosine Triphosphate; D003520:Cyclophosphamide; D002746:Chlorpromazine
ADENOSINE TRIPHOSPHATE; ANTIMETABOLITES; ANTINEOPLASTIC AGENTS; CARCINOMA 256, WALKER; CHLORPROMAZINE; CYCLOPHOSPHAMIDE; EXPERIMENTAL LAB STUDY; METABOLISM; MITOCHONDRIA; NEOPLASMS, EXPERIMENTAL; PHARMACOLOGY; RATS; SARCOMA, JENSEN; TRIIODOTHYRONINE